Novogen Ltd. (NASDAQ:NVGN)’s share price gapped up prior to trading on Thursday . The stock had previously closed at $1.79, but opened at $1.83. Novogen shares last traded at $2.01, with a volume of 158,973 shares traded.

The firm’s market cap is $34.46 million. The company has a 50-day moving average price of $1.89 and a 200 day moving average price of $2.08.

Novogen Limited (Novogen) is a drug discovery company. The Company is primarily engaged in pharmaceutical research and development. The Company’s operations include CanTx Inc, its United States-based joint venture company with Yale University. Novogen has two drug technology platforms (the superbenzopyrans (SBPs) and anti-tropomyosins (ATMs)) yielding drug candidates that have application across a range of degenerative diseases.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.